Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00674882 · ClinicalTrials.gov registry record
Protocol For Collecting Long-Term Follow-Up Data On Recipients of Bone Marrow and Blood Stem Cell Transplant
A clinical trial of Hematopoietic Stem Cell Transplantation, sponsored by St. Jude Children's Research Hospital.
- Completed
- Registry status
- 637
- Enrollment target
- 1
- Study location
NCT00674882 is a study of Hematopoietic Stem Cell Transplantation that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 637 participants, below the 9,765-participant average among 26 other Hematopoietic Stem Cell Transplantation trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00674882, a study of Hematopoietic Stem Cell Transplantation, has completed, sponsored by St. Jude Children's Research Hospital.
- COMPLETED
- Registry status
- 637 participants
- Enrollment target
- 1
- Study location
Study Summary
This protocol allows for ongoing data collection to assess the long-term clinical and psychosocial outcomes of pediatric patients who have received a hematopoietic stem cell transplant at St. Jude Children's Research Hospital.
Conditions Studied
Interventions
- OTHER Data Collection
Study Locations (1)
Tennessee
- St. Jude Children's Research Hospital - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 637 participants |
| Start Date | 2019-11-07 |
| Est. Completion | 2022-10-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00674882
The ClinicalTrials.gov registry entry for NCT00674882 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 637 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 9,765-participant average among 26 other Hematopoietic Stem Cell Transplantation trials with a reported enrollment target (93% lower). The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hematopoietic Stem Cell Transplantation appearing as the primary indexed condition, and to 1 intervention - of which Data Collection is the first listed.
NCT00674882 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT00674882 about?
NCT00674882 is a clinical study titled "Protocol For Collecting Long-Term Follow-Up Data On Recipients of Bone Marrow and Blood Stem Cell Transplant". This protocol allows for ongoing data collection to assess the long-term clinical and psychosocial outcomes of pediatric patients who have received a hematopoietic stem cell transplant at St. Jude Children's Research Hospital.
What is the current status of trial NCT00674882?
This trial is currently completed. The enrollment target is 637 participants. The study started on 2019-11-07. Estimated completion is 2022-10-03.
What conditions does trial NCT00674882 study?
This clinical trial studies the following conditions: Hematopoietic Stem Cell Transplantation.
What interventions are being tested in trial NCT00674882?
The interventions under investigation include: Data Collection (OTHER).
Who is sponsoring clinical trial NCT00674882?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00674882 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hematopoietic Stem Cell Transplantation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation
RECRUITING · Phase 1
-
Employment Support After Hematopoietic Stem Cell Transplantation
RECRUITING · NA
-
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
RECRUITING · Phase 2
-
Metagenomics Next-generation Sequencing Approach to Detect Microbial DNA/RNA Overtime in Individuals Undergoing Hematopoietic Stem Cell Transplant
RECRUITING
-
Long-Term Follow-up of People Undergoing Hematopoietic Stem Cell Transplantation
RECRUITING
-
Cultural Tailoring and Pilot Testing of an Inpatient Yoga Therapy Program for Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation in India, Tanzania, and the United States
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.